<unk>  refers to a regimen consisting of  fludarabine, amsacrine, cytarabine (Ara-C) and<unk> phalan used to upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia.
FLAMSA-MEL regimen
R-CDOP regimen
CDOP regimen
ICE-R regimen
MINE-R regimen
ACVBP-R regimen
R-CVP regimen
MACOP-B regimen